Stay updated on EGFR Mutant Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the EGFR Mutant Lung Cancer Clinical Trial page.

Latest updates to the EGFR Mutant Lung Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page displays the ClinicalTrials.gov record for a terminated Phase 2 study, including its eligibility criteria, treatment arms, outcomes, locations, and record dates.SummaryDifference51%

- Check14 days agoChange DetectedThe footer now shows site revision v3.8.0 instead of v3.7.2. The study page content remains a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA sitewide banner announces NIH website transition updates and notes that NIH content may use “Super Intelligence” instead of “Artificial Intelligence.”SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site revision label in the footer changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now shows Revision: v3.7.0 and a large set of non-core metadata terms and links have been removed, indicating a cleanup of ancillary information rather than changes to the study details.SummaryDifference19%

Stay in the know with updates to EGFR Mutant Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EGFR Mutant Lung Cancer Clinical Trial page.